# Topaz Biosciences, Inc. — Form D

Topaz Biosciences, Inc. of Emeryville, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-25. The offering totals $3.2M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-03-25
- Form: D
- Accession: 0002062605-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $1.4M
- Remaining: $1.7M
- Investors: 8
- Date of first sale: 2025-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542023

## Issuer

- Name: Topaz Biosciences, Inc.
- CIK: 0002062605
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1250 45th Street, Suite 320, Emeryville, CA, 94608
- Phone: 415-572-3901

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Oliver Liu | Director | Emeryville, CA |
| Jennifer Shock | Director | Emeryville, CA |
| Teresa Shock | Director | Emeryville, CA |
| Caroline Hadfield | Executive Officer | Emeryville, CA |
| Oliver Liu | Executive Officer | Emeryville, CA |
| Jennifer Shock | Executive Officer | Emeryville, CA |

## More

- [CIK 2062605 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062605&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002062605-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.